Celadon Pharma

News

Celadon Pharmaceuticals has secured the final approval needed to start a large-scale trial of its cannabinoid therapy for chronic pain in the UK.

News

London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.